NCR2 and melanoma: PGE2 secretion in thyroid cancer and melanoma inhibits the expression of NKG2D, NKp44, NKp30, and TRAIL on PB-NK cells and their functional maturation leading to suppressed NK cell cytotoxicity (10, 52) (Figure 3).